Treatment patterns in patients with acute myeloid leukemia in the United States: a cross-sectional, real-world survey

Author:

Medeiros Bruno C.1,Pandya Bhavik J.2,Hadfield Anna34,Pike James3,Wilson Samuel2,Mueller Cynthia2,Bui Cat N.25,Flanders Scott C.26,Rider Alex3,Horvath Walsh L. Elise27

Affiliation:

1. Stanford Comprehensive Cancer Center, Stanford University, Stanford, CA, USA;

2. Health Economics and Outcomes Research, Astellas Pharma, Inc., Northbrook, IL, USA;

3. Adelphi Real World, Adelphi Group, Cheshire, UK;

4. Currently at Programme Excellence, Qiagen, Manchester, UK;

5. Currently at Health Economics and Outcomes Research, AbbVie, Inc., Mettawa, IL, USA;

6. Currently at Health Economics and Outcomes Research, Dendreon Pharmaceuticals, LLC, Seattle, WA, USA;

7. Currently at Medical Affairs, IQVIA Biotech, Columbus, OH, USA

Funder

Astellas Pharma Inc.

Publisher

Informa UK Limited

Subject

General Medicine

Reference22 articles.

1. Leukemia & Lymphoma Society. Acute Myeloid Leukemia [Internet]. 2017. [cited 2018 Apr 24]. Available from: https://www.lls.org/sites/default/files/file_assets/PS32_AML_BookletFINAL_with_insert.pdf

2. National Cancer Institute Surveillance, Epidemiology, and End Results program. Cancer stat facts: acute myeloid leukemia (AML) (1992–2015). [Internet]. 2018. [cited 2018 Apr 24]. Available from: https://seer.cancer.gov/statfacts/html/amyl.html

3. National Cancer Institute Surveillance, Epidemiology, and End Results Program. SEER Cancer Statistics Review 1975–2014 SEER incidence rates, age-adjusted and age-specific rates, by race and sex [Internet]. 2018. [cited 2018 Apr 24]. Available from: https://seer.cancer.gov/csr/1975_2014/results_single/sect_13_table.13.pdf

4. Genetic Abnormalities and Challenges in the Treatment of Acute Myeloid Leukemia

5. National Comprehensive Cancer Network Clinical practice guidelines in oncology. Acute myeloid leukemia. Version 1 [Internet]. 2018 [cited 2018 Apr 24]. Available from: www.nccn.org/professionals/physician_gls/pdf/aml.pdf

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3